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In epidemiologic studies, non-Hodgkin's lymphoma (NHL) has been associated with exposure to
chemicals such as phenoxyacetic acids; chlorophenols; dioxins; organic solvents including
benzene, polychlorinated biphenyls, chlordanes; and immunosuppressive drugs. Experimental
evidence and clinical observations indicate that these chemicals may impair the immune system.
The risk is increased for NHL in persons with acquired and congenital immune deficiency as well
as autoimmune disorders. Also, certain viruses have been suggested to be of etiologic
significance for NHL. In some cases of NHL the common mechanism for all these agents and
conditions may be immunosuppression, possibly in combination with viruses.- Environ Health
Perspect 106(Suppl 2):679-681 (1998). http://ehpnetl.niehs.nih.gov/docs/1998/Suppl-2/
679-68lhardeIl/abstract.html
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During the last two decades, non-Hodgkin's
lymphoma (NHL) has been one of the
most rapidly increasing malignant diseases
in the developed countries (1). The eti-
ology of NHL is not well understood
although the knowledge in this respect has
accumulated during the past decades.
In this paper etiologic aspects are
discussed with some emphasis on results of
Swedish studies. The aim is not to give a
thorough review on the epidemiology of
NHL; this is found in other papers. Some
hypotheses on etiology are discussed at the
end ofthe paper.
A number ofNHL patients with expo-
sure to phenoxyacetic acid herbicides and
to chlorophenol impregnating agents were
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first reported in 1979 (2). Subsequent
studies on malignant lymphoma including
both Hodgkin's disease and NHL showed
increased odds ratios for exposure to phe-
noxyacetic acids, chlorophenols, or organic
solvents including benzene (3-8).
Whether impurities such as dioxins and
dibenzofurans in chlorophenols and certain
phenoxyacetic acids are ofetiologic signifi-
cance has been discussed. In that context it
is of interest that the levels ofsome dioxin
and dibenzofuran congeners were signifi-
cantly higher in the adipose tissue of 7
patients with malignant lymphoproliferative
disease than in 12 surgical controls without
malignant disease (9). Also, the 2,3,7,8-
tetrachlorodibenzo-p-dioxin (TCDD) toxic
equivalent factor was significantly higher in
these 7 patients; 64.7 pg/g wet basis
(19.9-187) compared to 29.7 (12.9-53.4),
p= 0.04 (Wilcoxon's two-tailed test). Six
cases reported potential occupational
exposure to dioxins and dibenzofurans. One
case was a high consumer of fish from the
Baltic sea.
Similarly, the higher chlorinated
congeners of polychlorinated biphenyls
(PCBs) were significantly elevated in 27
NHL patients compared with 17 surgical
controls without malignancy (10). The
mean sum of PCBs was 1614 ng/g lipid
(637-4705) in the cases compared to 1213
(366-2282) in the controls with a
Wilcoxon's two-tailed p value of 0.06
(Figure 1). Also, for the insecticide chlor-
dane, significantly higher concentrations
were found in NHL cases than in controls
in the same study (11). The sum ofchlor-
danes in the 27 NHL patients was 180 ng/g
lipid (48.3-678) compared to 92.8
(37.0-164) in the 17 surgical controls,
p= 0.002 (Figure 2). No significant dif-
ferences were found between cases and
controls for dioxins, dibenzofurans, hexa-
chlorobenzene, or p,p'-DDE. The results
reflect exposure, mainly through the food
chain, to environmental concentrations of
these organochlorines (12,13). It should be
noted that on the basis of occupational
exposure to the studied chemicals the case
group was not included. Exposure to PCBs
and increased risk of NHL appear to be
corroborated in a recent study from the
United States (14).
Both PCBs and chlordanes are immuno-
toxic substances (15,16). Immunotoxic
effects also have been reported for other
chemicals such as dioxins (17-19), chloro-
phenols (20,21), and organic solvents
(22,23), which have been associated with
increased risk for NHL. Recent evidence
shows immunologic changes among farmers
exposed to phenoxy herbicides (24). The
incidence ofNHL increases with age and an
age-related decline in the protective immune
response has been reported and may be
added to the list of immunosuppressive
factors (25).
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Figure 1. Box plot of the sum of PCBs expressed as
nanogram per gram of lipid for cases and controls where
50% of the subjects have values within the box; median
value, 25th, and 75th percentiles are shown. Smallest
and largest values that are not outliers as shown by
bars. o, outlier more than 1.5 box length from 75th per-
centile; *, extreme more than 3 box lengths from the
75th percentile. n, numbers of cases and controls.
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Figure 2. Box plot ofthe sum of chlordanes expressed
as nanogram per gram of lipid for cases and controls
so, outlier more than 1.5 box length from 75th per-
centile; *, extreme more than 3 box lengths from the
75th percentile. n, numbers ofcases and controls.
An increased incidence of NHL has
been reported after blood transfusion
(26). Both temporary immunosuppres-
sion after blood transfusion and transmis-
sion of viruses have been discussed as
possible mechanisms. Furthermore,
increased incidence of NHL has been
reported among patients with congenital
immune deficiency (27) or autoimmune
diseases such as rheumatoid arthritis
(28,29), Sjogren's syndrome (30), and sys-
temic lupus erythematosus (31). It is also
well known that immunosuppressive ther-
apy increases the risk for NHL (32,33).
NHL has also been reported to be a late
complication ofcertain chemotherapy and
radiotherapy regimens in patients with
Hodgkin's disease (34).
Ultraviolet (UV) irradiation may cause
immunosuppression (35). However, studies
that have especially evaluated the possible
role ofUVlight in NHLhave notshown an
increased risk for outdoor occupations
(5,36) orexposure to sunlight (37).
Epstein-Barr virus (EBV), a herpes
virus, has been associated with Burkitt
lymphoma (38). EBV is persistent in over
95% of adults in nasopharyngeal epi-
thelium and B cells (39). Normally, EBV
production is held back by active cellular
and humoral immune mechanisms. In
immunodeficiency states, this balance may
be disrupted, and EBV-infected B cells
begin to proliferate (40).
The retrovirus human immuno-
deficiency virus-I is endemic in parts ofthe
world and has been demonstrated to cause
adult T-cell leukemia/lymphoma (41).
Other retroviruses such as human immuno-
deficiency viruses are associated with
acquired immune deficiency syndrome and
an increased incidence ofNHL (42).
Finally, a working group at the Inter-
national Agency for Research on Cancer
recently classified TCDD as a Group 1
human carcinogen (43). It was concluded
that based on epidemiologic evidence expo-
sure to TCDD increases the risk for all can-
cers combined, but with higher relative risks
forNHLandsoft-tissuesarcoma.
It is postulated that exposures or condi-
tions that affect the immune system
increase the risk for NHL. Virus prolifera-
tion is under immunologic surveillance and
impairment of the immune system may
cause B-cell lymphomas (40) and also T-
cell lymphoma (44). Studies ofthe interac-
tion between immune response, viruses,
and various agents, therefore, would be of
great interest.
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